Trial intelligence / Profile preview

KeraStat Gel with Morphine for Chronic Wound Pain

NCT05217160Phase 4Recruiting

Sponsor
Metis Foundation
Start
May 2021
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of morphine hydrochloride, sponsored by Metis Foundation. Started May 2021; status: recruiting.

02

Drugs

morphine hydrochloride

Beyond the preview

Go deeper on NCT05217160.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05217160.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call